Literature DB >> 17279313

Cellular internalization of proinsulin C-peptide.

E Lindahl1, U Nyman, E Melles, K Sigmundsson, M Ståhlberg, J Wahren, B Obrink, J Shafqat, B Joseph, H Jörnvall.   

Abstract

Proinsulin C-peptide is known to bind specifically to cell membranes and to exert intracellular effects, but whether it is internalized in target cells is unknown. In this study, using confocal microscopy and immunostained or rhodamine-labeled peptide, we show that C-peptide is internalized and localized to the cytosol of Swiss 3T3 and HEK-293 cells. In addition, transport into nuclei was found using the labeled peptide. The internalization was followed at 37 degrees C for up to 1 h, and was reduced at 4 degrees C and after preincubation with pertussis toxin. Hence, it is concluded to occur via an energy-dependent, pertussis toxin-sensitive mechanism and without detectable degradation within the experimental time course. Surface plasmon resonance measurements demonstrated binding of HEK-293 cell extract components to C-peptide, and subsequent elution of bound material revealed the components to be intracellular proteins. The identification of C-peptide cellular internalization, intracellular binding proteins, absence of rapid subsequent C-peptide degradation and apparent nuclear internalization support a maintained activity similar to that of an intracrine peptide hormone. Hence, the data suggest the possibility of one further C-peptide site of action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279313     DOI: 10.1007/s00018-007-6467-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

Review 1.  The physiological basis of intracrine stem cell regulation.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

2.  C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes.

Authors:  P Luppi; X Geng; V Cifarelli; P Drain; M Trucco
Journal:  Diabetologia       Date:  2009-08-07       Impact factor: 10.122

Review 3.  C-Peptide and its career from innocent bystander to active player in diabetic atherogenesis.

Authors:  Corinna Lebherz; Nikolaus Marx
Journal:  Curr Atheroscler Rep       Date:  2013-07       Impact factor: 5.113

4.  Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein.

Authors:  R S Mughal; J L Scragg; P Lister; P Warburton; K Riches; D J O'Regan; S G Ball; N A Turner; K E Porter
Journal:  Diabetologia       Date:  2010-05-12       Impact factor: 10.122

5.  Human Eb peptide: not just a by-product of pre-pro-IGF1b processing?

Authors:  J Durzyńska; A Wardziński; M Koczorowska; A Goździcka-Józefiak; E R Barton
Journal:  Horm Metab Res       Date:  2013-01-18       Impact factor: 2.936

6.  A microfluidic technique for monitoring bloodstream analytes indicative of C-peptide resistance in type 2 diabetes.

Authors:  Teresa D'Amico Oblak; Jennifer A Meyer; Dana M Spence
Journal:  Analyst       Date:  2008-11-27       Impact factor: 4.616

7.  Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway.

Authors:  P Luppi; V Cifarelli; H Tse; J Piganelli; M Trucco
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

Review 8.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

9.  Proinsulin C-peptide regulates ribosomal RNA expression.

Authors:  Emma Lindahl; Ulrika Nyman; Farasat Zaman; Carina Palmberg; Anna Cascante; Jawed Shafqat; Masaharu Takigawa; Lars Sävendahl; Hans Jörnvall; Bertrand Joseph
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

10.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.